The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public

Latest topics page 52

Topics ordered by most recent activity across all 71 subcategories.

1,535 topics · page 52 of 52

TopicParticipantsRepliesViewsActivity
Two sessions a week versus four: what the evidence supports — a second dataset
Two sessions a week versus four: what the evidence supports — a second dataset — setting out what I have, and where I think it stops being reliable. Maintenance rather than loss, which is the part of this…
RGKCIRKKSE+28 32 579 2y
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version
Posting this under the heading it deserves: Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Everything below is what sits behind that. Reporting something rather than…
JSSSIBSBSO+138 148 1.8k 2y
What happens when a maintainer goes quiet
The question in the title: What happens when a maintainer goes quiet I will give what I have already checked below so nobody repeats it. Nominating something for promotion into the documentation commons. The…
NOBAIHN+3 7 13k 2.1y
Spreadsheets: an appreciation
On the subject in the title: Spreadsheets: an appreciation Working notes rather than a conclusion. Lower-stakes topic, but the sourcing rule still applies if anyone makes a claim. Something adjacent that I…
ONJAVFAACA+26 30 25k 2.1y
Assessing a warm arrival: the decision process — one year on
Assessing a warm arrival: the decision process — one year on Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better…
KACFZLKCCL+125 138 1.7k 2.2y